Phase II multicenter trial: first-line immunochemotherapy with or without radiotherapy in metastatic esophageal squamous cell cancer (SCR-ESCC-01)

Future Oncology, Ahead of Print.

Source: Future Oncology - November 8, 2023 Category: Cancer & Oncology Authors: Yue Li Lin Lin Jun Liu Xu-Wei Cai Qin Zhang Xin-Yun Song Sheng-Guang Zhao Xiu-Mei Ma Xiao-long Fu Wen Yu Source Type: research